Niki BioSolutions, Inc. Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss
Niki BioSolutions, Inc. (NIKI) reported Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss of $6.43 million for the 12-month period ending 2023-12-31, per its 6-K filed 2025-10-08.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments · last filed 2025-10-08
| Period end | Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month |
|---|---|
| 2023-12-31 | $6.43M 6-K · filed 2025-10-08 |
| 2022-12-31 | $6.11M 6-K · filed 2025-10-08 |